ASTRAZENECA PHARMA INDIA
Back to All Ratios
|
ASTRAZENECA PHARMA INDIA Last 5 Year Cash Earnings per Share (CEPS) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 62.29 | 70.58 | 46.22 | 31.42 | 45.37 |
What is the latest Cash Earnings per Share (CEPS) ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 62.29 |
| Mar2024 | 70.58 |
| Mar2023 | 46.22 |
| Mar2022 | 31.42 |
| Mar2021 | 45.37 |
How is Cash Earnings per Share (CEPS) of ASTRAZENECA PHARMA INDIA Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 62.29 | -11.75 | |
| Mar2024 | 70.58 | 52.70 | |
| Mar2023 | 46.22 | 47.10 | |
| Mar2022 | 31.42 | -30.75 | |
| Mar2021 | 45.37 | - | |
Other Financial Ratios of ASTRAZENECA PHARMA INDIA
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹19,631.9 Cr | -5.3% | -11.3% | -8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,713.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,811.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,052.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,927.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,602.7 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -5.3% |
-11.3% |
-8% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses